Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- BURL +9.9%, DLTR +8.6%, SIG +7.7%, SBLK +6.5%, BKS +5.2%, CPRT+4.9%, MOV +4.9%, HRL +4.8%, ADI +4.6%, CBRL +4.5%
- DSW +4%, ENTA +3.1%, DAKT +3%, CPB +2.7%, SINA +2.5%, TECD +2.3%,TEDU +1.5%, GLBS +1%, EVLV +0.9%, QIWI +0.6%
M&A news:
- HRL +4.8% (Sells Farmer John, Saag's Specialty Meats, and three farm operations for $145 mln; increases dividend)
- RIGP +4.7% (Transocean (RIG) agrees to increase the consideration for its pending acquisition of each outstanding common unit of Transocean Partners)
- WLL +0.7% (To sell its 50% interest in its Robinson Lake natural gas processing plant and associated natural gas gathering system and its 50% interest in its Belfield natural gas processing plant and associate
Select metals/mining stocks trading higher:
- VALE +7.6%, MT +5.6%, CLF +3.3%, X +3%, BBL +2.5%, BHP +2.2%, FCX+2%, RIO +1.9%, SLV +1%, AU +0.9%
Other news:
- AVXL +22.2% (announces a positive 41-week update from its Phase 2a study in mild-to-moderate Alzheimer's disease patients for ANAVEX 2-73)
- TGTX +7.4% (announces 'positive' DSMB recommendation for continuation of the UNITY-CLL phase 3 trial)
- CTIC +4.8% (To present data from the randomized Phase 3 PERSIST-2 clinical trial at ASH)
- BGNE +3.4% (Baker Bros increases stake)
- TLLP +3.2% (Announces $1.1 bln in acquisitions, sees immediate accretion to unitholders)
- DG +2.9% (in sympathy with DLTR)
- AGN +0.7% (FDA has cleared the XEN Glaucoma Treatment System for use in the U.S)
Analyst comments:
- TXMD +4.3% (initiated with a Outperform at Oppenheimer)
- CRC +2.3% (upgraded to Equal-Weight from Underweight at Morgan Stanley)
- AMX +0.8% (upgraded to Buy from Neutral at BofA/Merrill)